This study aimed to explore the biological role and molecular mechanism of long noncoding RNA (lncRNA) rhabdomyosarcoma 2‐associated transcript (RMST) in regulating microglial activation. Mouse microglial BV2 cells were cultured to establish the cell model of cerebral ischemic stroke by oxygen–glucose deprivation (OGD). We observed highly expressed RMST, increased expression of M1, and decreased expression of M2 markers in BV2 microglial cells stimulated with OGD. These alterations were reversed by RMST knockdown. Activation of transforming growth factor‐beta‐activated kinase 1 (TAK1)‐mediated nuclear factor‐κB (NF‐κB) pathway was observed upon OGD stimulation, which was promoted by RMST through competitively binding with heterogeneous nuclear ribonucleoprotein K (hnRNPK), confirmed by RNA pull down and RNA immunoprecipitation (RIP) assays. Furthermore, RMST overexpressing‐BV2 cells effectively enhanced neuronal apoptosis. In conclusion, RMST promoted OGD‐induced microglial M1 polarization by competitively interacting with hnRNPK via TAK1‐mediated NF‐κB pathway, which will provide a basis for understanding the pathogenesis of cerebrovascular diseases.
Background: Glioblastoma (GBM) is one of the most malignant and aggressive primary brain tumors. The incurability of glioblastoma is heavily influenced by the glioma microenvironment. FTY720, a potent immunosuppressant, has been reported to exert anti-tumor effects in glioblastoma. However, the impact of FTY720 on the glioma microenvironment remains unclear. Methods: We examined the effects of FTY720 on the distribution and polarization of glioma-associated microglia and macrophages (GAMs) in glioma-bearing rats using immunofluorescence staining. qRT-PCR and Western blotting were used to detect the expressions of CXCR4 and MAPK pathway-related signal molecules on microglia in the coculture system. The levels of inflammatory factors were tested via ELISA. Wound healing assay and Matrigel invasion assay were used to determine the migration and invasion of C6 glioma cells. Results: We discovered that FTY720 could inhibit the growth, migration, and invasion of glioma by targeting GAMs to impede their effect on glioma cells. Simultaneously, FTY720 could block the chemoattraction of GAMs by inhibiting MAPK-mediated secretion of IL-6 through increased internalization of CXCR4. Moreover, microglia and macrophages are polarized from pro-glioma to an anti-tumor phenotype. Conclusion: These results provide novel insights into the inhibitory effects of FTY720 on glioma by targeting GAMs–glioma interaction in the tumor microenvironment.
Several studies have identified an association between the gut microbiome and post-stroke depression(PSD), and Helicobacter pylori(H. pylori) infection cause significant alterations in the composition of the gastrointestinal microbiome. However, evidence regarding the role of the H. pylori infection in promoting PSD is still lacking. Here, we conducted a retrospective study to explore risk factors associated with PSD. Patients with cerebral infarction were consecutively enrolled from December 2021 to October 2022. The diagnosis of PSD is based on the DSM-V criteria, and the Hamilton Depression Rating Scale(HAMD) was used to identify patients with PSD. White matter lesions were evaluated using magnetic resonance imaging(MRI) and H. pylori infection was detected by 13C-urea breath test. Further, 16S rRNA gene sequencing was used to evaluate the changes in gut microbiota composition of fecal samples from PSD patients. The concentration of short-chain fatty acids(SCFAs) was determined by gas chromatography-mass spectrometry(GC-MS). Multivariate regression analysis showed that deep white matter lesions(DWMLs) [odds ratio(OR) 3.382, 95% confidence interval(CI) 1.756-6.512; P = 0.001] and H. pylori infection(OR 2.186, 95% CI 1.149-4.159; P = 0.017) were the independent risk factors for PSD. Patients with H. pylori infection had more severe depressive symptoms than patients without infection. Intestinal microbiota was significantly different between H. pylori-positive PSD[H. pylori(+)] patients and H. pylori-negative PSD[H. pylori (-)] patients. Fecal SCFAs concentrations were significantly reduced in the H. pylori(+) group compared to the negative ones. DWMLs and H. pylori infection may play important roles in the development of PSD. H. pylori infection is likely to be involved in the pathogenesis of PSD by altering the intestinal flora.
Several studies have identified an association between the gut microbiome and post-stroke depression (PSD). As a common gastric infection bacteria, Helicobacter pylori (H. pylori) infection cause significant alterations in the composition of the gastrointestinal microbiome, but relationship between H. pylori infection and PSD is still limited. Here, we conducted a retrospective study to assess risk factors associated with PSD. A total of 183 patients with ischemic stroke were enrolled and their depression scores, imaging features and clinical data were analyzed. Multivariate logistic regression analysis showed that deep white matter lesions (DWMLs) and H. pylori infection were the independent risk factors for PSD. Further analysis indicated that patients with H. pylori-positive infection [H. pylori (+)] had more severe depressive symptoms than those with negative infection [H. pylori (-)]. Fecal 16S rRNA gene sequencing analysis revealed statistically differences in intestinal flora between H. pylori (+) patients and H. pylori (-) patients. The DESeq2 analysis indicated that Akkermansia muciniphila, Bacteroides dorei, and Fusobacterium ulcerans levels were significantly decreased, while Megamonas funiformis and Bifidobacterium adolescentis were more abundant in the H. pylori (+) group. GC-MS revealed that short-chain fatty acids (SCFAs) concentrations were significantly different between the two groups, and fecal SCFAs concentrations reduced in the H. pylori (+) group. In conclusion, DWMLs and H. pylori infection may play important roles in the development of PSD. H. pylori infection is likely to be involved in the pathogenesis of PSD by altering the intestinal flora.